Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients

26 Oct 2023

Abstract excerpt

BACKGROUND: Even after 3 years from SARS-CoV-2 identification, COVID-19 is still a persistent and dangerous global infectious disease. Significant improvements in our understanding of the disease pathophysiology have now been achieved. Nonetheless, reliable and accurate biomarkers for the early stratification of COVID-19 severity are still lacking. Long noncoding RNAs (LncRNAs) are ncRNAs longer than 200...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to COVID-19 Clinical Research Studies
Share to Immune responses and vaccinations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37884975
DOI: 10.1186/s12967-023-04497-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patientsPMID 37884975Read ↗

HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the Peripheral Blood Mononuclear Cells of COVID-19 patientsSemantic proximity Read ↗

Identification of PBMC-based molecular signature associational with COVID-19 disease severitySemantic proximity Read ↗

Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19Semantic proximity Read ↗

Integrative Transcriptomic Profiling of NK Cells and Monocytes: Advancing Diagnostic and Therapeutic Strategies for COVID-19Semantic proximity Read ↗

Longitudinal peripheral blood transcriptional analysis of COVID-19 patients captures disease progression and reveals potential biomarkersSemantic proximity Read ↗

The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19Semantic proximity Read ↗

Identification of potentional immunological biomarkers of COVID-19 by blood transcriptome analysisSemantic proximity Read ↗

Comparative transcriptomic analyses of peripheral blood mononuclear cells of patients with non-pneumonia and severe pneumonia at 1 year-Long-COVID-19Semantic proximity Read ↗

Single-cell RNA sequencing reveals HIF1A as a severity-sensitive immunological scar in circulating monocytes of convalescent comorbidity-free COVID-19 patientsSemantic proximity Read ↗

The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 diseaseSemantic proximity Read ↗

Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after RecoverySemantic proximity Read ↗

Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.